Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-02

Clinical Trial Update: An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)

View source ↗

Summary

The study completed an observational assessment of Mircera (methoxy polyethylene glycol-epoetin beta) in patients with anemia associated with chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED